Suppr超能文献

使用DECoN在靶向二代测序(NGS)面板中准确临床检测外显子拷贝数变异。

Accurate clinical detection of exon copy number variants in a targeted NGS panel using DECoN.

作者信息

Fowler Anna, Mahamdallie Shazia, Ruark Elise, Seal Sheila, Ramsay Emma, Clarke Matthew, Uddin Imran, Wylie Harriet, Strydom Ann, Lunter Gerton, Rahman Nazneen

机构信息

Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.

Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK.

出版信息

Wellcome Open Res. 2016 Nov 25;1:20. doi: 10.12688/wellcomeopenres.10069.1.

Abstract

Targeted next generation sequencing (NGS) panels are increasingly being used in clinical genomics to increase capacity, throughput and affordability of gene testing. Identifying whole exon deletions or duplications (termed exon copy number variants, 'exon CNVs') in exon-targeted NGS panels has proved challenging, particularly for single exon CNVs.  We developed a tool for the Detection of Exon Copy Number variants (DECoN), which is optimised for analysis of exon-targeted NGS panels in the clinical setting. We evaluated DECoN performance using 96 samples with independently validated exon CNV data. We performed simulations to evaluate DECoN detection performance of single exon CNVs and to evaluate performance using different coverage levels and sample numbers. Finally, we implemented DECoN in a clinical laboratory that tests and with the TruSight Cancer Panel (TSCP). We used DECoN to analyse 1,919 samples, validating exon CNV detections by multiplex ligation-dependent probe amplification (MLPA).  In the evaluation set, DECoN achieved 100% sensitivity and 99% specificity for BRCA exon CNVs, including identification of 8 single exon CNVs. DECoN also identified 14/15 exon CNVs in 8 other genes. Simulations of all possible BRCA single exon CNVs gave a mean sensitivity of 98% for deletions and 95% for duplications. DECoN performance remained excellent with different levels of coverage and sample numbers; sensitivity and specificity was >98% with the typical NGS run parameters. In the clinical pipeline, DECoN automatically analyses pools of 48 samples at a time, taking 24 minutes per pool, on average. DECoN detected 24 BRCA exon CNVs, of which 23 were confirmed by MLPA, giving a false discovery rate of 4%. Specificity was 99.7%.  DECoN is a fast, accurate, exon CNV detection tool readily implementable in research and clinical NGS pipelines. It has high sensitivity and specificity and acceptable false discovery rate. DECoN is freely available at www.icr.ac.uk/decon.

摘要

靶向新一代测序(NGS)检测板越来越多地应用于临床基因组学,以提高基因检测的能力、通量和可承受性。在外显子靶向NGS检测板中识别全外显子缺失或重复(称为外显子拷贝数变异,“外显子CNV”)已被证明具有挑战性,尤其是对于单外显子CNV。我们开发了一种用于检测外显子拷贝数变异的工具(DECoN),该工具针对临床环境中外显子靶向NGS检测板的分析进行了优化。我们使用96个具有独立验证的外显子CNV数据的样本评估了DECoN的性能。我们进行了模拟,以评估DECoN对单外显子CNV的检测性能,并评估使用不同覆盖水平和样本数量时的性能。最后,我们在一个使用TruSight癌症检测板(TSCP)进行检测的临床实验室中实施了DECoN。我们使用DECoN分析了1919个样本,通过多重连接依赖探针扩增(MLPA)验证外显子CNV检测结果。在评估集中,DECoN对BRCA外显子CNV的灵敏度达到100%,特异性达到99%,包括识别出8个单外显子CNV。DECoN还在其他8个基因中识别出14/15个外显子CNV。对所有可能的BRCA单外显子CNV进行模拟,缺失的平均灵敏度为98%,重复的平均灵敏度为95%。在不同的覆盖水平和样本数量下,DECoN的性能仍然优异;在典型的NGS运行参数下,灵敏度和特异性均>98%。在临床流程中,DECoN每次自动分析48个样本的混合样本,每个混合样本平均需要24分钟。DECoN检测到24个BRCA外显子CNV,其中23个经MLPA确认,假发现率为4%。特异性为99.7%。DECoN是一种快速、准确的外显子CNV检测工具,可轻松应用于研究和临床NGS流程。它具有高灵敏度和特异性以及可接受的假发现率。可在www.icr.ac.uk/decon免费获取DECoN。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f14c/5445955/1b386ba13dc4/wellcomeopenres-1-10849-g0000.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验